Wednesday, July 31, 2013

Global Business Survey: China Coronary Stent Market Trends 2013-2017

The demand for interventional medical core products has increased continuously with the improvement of living quality and the coming of aging society; PCI (percutaneous coronary intervention) surgical cases also increased year by year. In 2012, the usage quantity of coronary stent was about 633,600 sets and the market scale reached CNY 3.15 billion in China. 




The overall market share of domestic brands decreased to 65% in 2012 from 70% in 2011. However, the landscape of Top 3 enterprises was not changed; MicroPort still occupied the leading position with 23% market shares, following by LePu and Shandong JW with 21% and 20% market shares respectively.

In 2012, the major foreign brands Boston Scientific, Medtronic and Abbott strengthened the marketing efforts, and the market share of the three brands reached about 33% in China.

Huidian Research takes a view that, from the aspects of market scale, the annual growth rate of stent system will remain 8% globally on the whole. At present, cardiac interventional surgeries in some developed countries, such as Europe, America, Japan, are comparative mature, so the annual growth rate will continue to remain 3%-5%. While the stent system market of emerging countries represented by China, the annual growth rate will remain 10%-15% in the next five years, the usage quantity (sale volume) of stent system will reach 1.299 million sets.


To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172012     


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

No comments:

Post a Comment